Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $1.28 Million - $1.59 Million
-9,727 Reduced 87.65%
1,371 $222,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $411,134 - $520,204
3,827 Added 52.63%
11,098 $1.5 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $601,372 - $682,648
-5,652 Reduced 43.74%
7,271 $784,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $2.72 Million - $3.19 Million
-31,604 Reduced 70.98%
12,923 $1.13 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $2.33 Million - $3.53 Million
36,079 Added 427.07%
44,527 $3.39 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $2.62 Million - $3.35 Million
-39,833 Reduced 82.5%
8,448 $614,000
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $21.8 Million - $25.7 Million
-283,219 Reduced 85.44%
48,281 $3.89 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $26.3 Million - $31.1 Million
293,019 Added 761.46%
331,500 $30.7 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $13.8 Million - $18.4 Million
-149,619 Reduced 79.54%
38,481 $3.64 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $7.59 Million - $8.33 Million
84,800 Added 82.09%
188,100 $18.2 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $7.22 Million - $9.22 Million
103,300
103,300 $9.18 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hbk Investments L P Portfolio

Follow Hbk Investments L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Investments L P with notifications on news.